A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
Authors
Keywords
Cytokine-induced killer cells, hepatocellular carcinoma, immunotherapy, trans-arterial chemoembolization
Journal
JOURNAL OF CLINICAL IMMUNOLOGY
Volume 34, Issue 2, Pages 194-203
Publisher
Springer Nature
Online
2013-12-14
DOI
10.1007/s10875-013-9976-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma
- (2012) L. Liu et al. CLINICAL CANCER RESEARCH
- Surgical Resection of High-Risk Hepatocellular Carcinoma: Patient Selection, Preoperative Considerations, and Operative Technique
- (2010) Mark J. Truty et al. ANNALS OF SURGICAL ONCOLOGY
- Management of Small Hepatocellular Carcinoma: A Review of Transplantation, Resection, and Ablation
- (2010) William R. Jarnagin ANNALS OF SURGICAL ONCOLOGY
- Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery
- (2010) Hui Li et al. CYTOTHERAPY
- Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)
- (2010) C. Hontscha et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients
- (2010) Jing-Ting Jiang WORLD JOURNAL OF GASTROENTEROLOGY
- T Cell-Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective
- (2009) A. Shablak et al. CLINICAL CANCER RESEARCH
- Selection for Resection of Hepatocellular Carcinoma and Surgical Strategy: Indications for Resection, Evaluation of Liver Function, Portal Vein Embolization, and Resection
- (2008) Dario Ribero et al. ANNALS OF SURGICAL ONCOLOGY
- In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
- (2008) R. Nishimura et al. BLOOD
- A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma
- (2008) Dong Hui et al. DIGESTIVE AND LIVER DISEASE
- Sorafenib in Hepatocellular Carcinoma: Separating the Hype From the Hope
- (2008) Robin K. Kelley et al. JOURNAL OF CLINICAL ONCOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer
- (2008) Kazuhiro Kakimi et al. LUNG CANCER
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now